PENTOTHAL Drug Patent Profile
✉ Email this page to a colleague
When do Pentothal patents expire, and what generic alternatives are available?
Pentothal is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in PENTOTHAL is thiopental sodium. There are four drug master file entries for this compound. Additional details are available on the thiopental sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENTOTHAL?
- What are the global sales for PENTOTHAL?
- What is Average Wholesale Price for PENTOTHAL?
Summary for PENTOTHAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 3 |
| Patent Applications: | 2,914 |
| DailyMed Link: | PENTOTHAL at DailyMed |
Recent Clinical Trials for PENTOTHAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Saint Vincent's Hospital, Korea | N/A |
| TC Erciyes University | Phase 4 |
| University Hospital, Aker | Phase 4 |
US Patents and Regulatory Information for PENTOTHAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | PENTOTHAL | thiopental sodium | SUSPENSION;RECTAL | 011679-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
